PAUL HAYES: Open Payments
NPI 1487617296 · NORWAY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 24 payments from 9 companies in 2025. Trend: 2023 $524 · 2024 $412 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $243 |
| Amgen Inc. | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Novo Nordisk Inc | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, OTEZLA, JARDIANCE, CAPLYTA, Ozempic, AREXVY, Kerendia, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
